Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Explore the typical budgeting hurdles people face and how to navigate them with actionable tips that fit real life.
12,330 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
A pre-retiree left for a rival firm and forfeited $74,000 in 401(K) employer matching by missing the vesting cliff. T...
Howard Lindzon explains that seed investing hinges on a power-law mindset: most bets fail, but one or two extraordina...
A health diagnosis that tilted retirement math retools how seniors claim Social Security and invest. This report expl...
Ethereum traded near a three-month low as risk-off conditions weighed on prices. Analysts flagged ethereum (eth) indi...
A sudden regulatory shift around tokenized stocks has sparked a wave of excitement and confusion. This Morning Minute...
A notable fund exited a sizable stake in Huron Consulting Group, locking in gains and signaling a disciplined approac...
Poet Technologies stock plummeted today as shares fell in a broad tech rotation. This deep dive explains the main dri...
A retiree explores how a $475,000 portfolio that quietly pays $2,800 a month relies on two overlooked income sources....
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Analysts debate the odds, but wall street thinks there’s a plausible path to roughly a 20% S&P 500 gain by 2027, driv...
The Cleveland Fed reports the five-year inflation outlook hasn’t been this high in 19 years, adding a new twist for i...